Christopher Simms - Jan 2, 2023 Form 4 Insider Report for IVERIC bio, Inc. (ISEE)

Role
SVP, Chief Commercial Officer
Signature
/s/ Todd D.C. Anderman, as Attorney-in-Fact for Christopher Simms
Stock symbol
ISEE
Transactions as of
Jan 2, 2023
Transactions value $
-$47,502
Form type
4
Date filed
1/4/2023, 05:33 PM
Previous filing
Dec 22, 2022
Next filing
Jul 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Options Exercise $0 +6.25K +21.89% $0.00 34.8K Jan 2, 2023 Direct F1
transaction ISEE Common Stock Sale -$47.5K -2.37K -6.81% $20.06 32.4K Jan 3, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Restricted Stock Units Options Exercise $0 -6.25K -25% $0.00 18.8K Jan 2, 2023 Common Stock 6.25K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
F2 Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on January 2, 2023.
F3 The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $19.91 to $20.56 on January 3, 2023 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
F4 On December 16, 2021, the Reporting Person was granted 25,000 restricted stock units, which vests with respect to 25% of the shares subject to the award in annual installments (on January 2, 2023, January 2, 2024, January 2, 2025 and January 2, 2026), subject to continued employment with the Registrant and the other terms and conditions of the Registrant's 2013 Stock Incentive Plan.